Geldanamycin

Drug Profile

Geldanamycin

Alternative Names: NSC 122750

Latest Information Update: 04 Aug 2009

Price : $50

At a glance

  • Originator Nonindustrial source
  • Developer Nonindustrial source; Pfizer
  • Class Benzoquinones; Cytostatic antibiotics; Macrocyclic lactams
  • Mechanism of Action Heat-shock protein inhibitors; Protein tyrosine kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Herpes simplex virus infections

Most Recent Events

  • 04 Aug 2009 Discontinued - Preclinical for Cancer in United Kingdom (unspecified route)
  • 04 Aug 2009 Discontinued - Preclinical for Cancer in USA (unspecified route)
  • 04 Aug 2009 Discontinued - Preclinical for Herpes simplex virus infections in China (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top